Clinical Trial Update: A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®, in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSI [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the diagnostic performance of C-Tb to QuantiFERON in subjects suspected of tuberculosis, with a safety assessment of C-Tb versus tubercu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• C-Tb
• Quantiferon

Snippet

Sponsor: Statens Serum Institut | Conditions: Tuberculosis | Phase 3 | Status: COMPLETED